Related Experiment Video
Updated: Jul 23, 2025

09:59
Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy
Published on: May 3, 2013
18.0K
Driving arginine catabolism to activate systemic autophagy
Yiming Zhang1, Brian N Finck2, Brian J DeBosch1,3
1Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110.
Autophagy Reports
|July 17, 2023
Summary
Arginine catabolism activates autophagy to treat obesity and related conditions. This process, enhanced by pegylated arginine deiminase, improves metabolic health in mice.
Area of Science:
- Cellular Biology
- Metabolic Diseases
- Biochemistry
Background:
- Autophagy is a vital cellular process for homeostasis, but its impairment is linked to aging and diseases.
- Current methods to induce autophagy, like fasting, are difficult to sustain, and drug targets are limited.
- Obesity and its complications present a significant health challenge with unmet therapeutic needs.
Purpose of the Study:
- To investigate arginine catabolism as a novel strategy to activate autophagy.
- To evaluate the therapeutic potential of arginine catabolism for treating obesity and associated metabolic disorders.
- To identify pharmacological agents that can leverage arginine catabolism for therapeutic benefit.
Main Methods:
- Utilized hepatocyte-specific transgenic activation of arginine catabolism in mice.
- Administered pegylated arginine deiminase, an anti-tumor drug, systemically in obese mouse models.
- Assessed effects on energy expenditure, insulin sensitivity, lipid profiles, and liver fat accumulation.
- Investigated the roles of hepatocyte FGF21 and whole-body BECN1 expression in mediating the observed effects.
Main Results:
- Hepatocyte-specific and systemic arginine catabolism activation significantly improved metabolic parameters in obese mice.
- Treatment led to increased energy expenditure, enhanced insulin sensitivity, and reduced dyslipidemia and hepatic steatosis.
- These beneficial effects were dependent on hepatocyte FGF21 and whole-body BECN1 expression.
- Pegylated arginine deiminase demonstrated efficacy in promoting autophagy and ameliorating obesity-related complications.
Conclusions:
- Arginine catabolism is a viable pathway to induce autophagy and treat metabolic diseases like obesity.
- Pharmacological targeting of arginine catabolism, using agents like pegylated arginine deiminase, offers a promising therapeutic strategy.
- This approach holds potential for managing obesity and its associated health issues by modulating cellular self-digestion processes.
Related Concept Videos
Delivery Pathways to the Lysosome
6.6K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.6K
Autophagy
4.4K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.4K
Autophagic Cell Death
3.5K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Amino Acid Catabolism
56
Microorganisms rely on proteins as an essential carbon and energy source, particularly in environments with limited polysaccharides or lipids. However, proteins are too large to cross the plasma membrane unaided, necessitating enzymatic degradation. Microbes secrete extracellular proteases and peptidases that hydrolyze proteins into peptides, which can then be transported across the membrane. Once inside the cell, intracellular proteases degrade these peptides into free amino acids, which...
56
cAMP-dependent Protein Kinase Pathways
6.4K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.4K

